Study Findings from Rockefeller University Broaden Understanding of Vaccine Development (Antibodies Elicited In Humans Upon Chimeric Hemagglutinin-based Influenza Virus Vaccination Confer Fcgr-dependent Protection In Vivo).
In: Vaccine Weekly, 2024-03-22, S. 2354-2354
serialPeriodical
Zugriff:
A recent study conducted at Rockefeller University in New York City has shed light on the development of vaccines. The researchers focused on the role of antibodies in providing protection against the influenza virus. They found that antibodies elicited by a chimeric hemagglutinin-based influenza virus vaccine conferred protection in mice that had been humanized for all classes of Fc gamma receptors (FcγRs), which are involved in immune responses. These findings have important implications for the design of influenza vaccines that can elicit optimal immune responses. [Extracted from the article]
Copyright of Vaccine Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Study Findings from Rockefeller University Broaden Understanding of Vaccine Development (Antibodies Elicited In Humans Upon Chimeric Hemagglutinin-based Influenza Virus Vaccination Confer Fcgr-dependent Protection In Vivo).
|
---|---|
Zeitschrift: | Vaccine Weekly, 2024-03-22, S. 2354-2354 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1074-2921 (print) |
Sonstiges: |
|